Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJK7Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,818
Award facts
- Contract value 100% obligated
- $65,817.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $65,817.61 to AmerisourceBergen Drug Corp for RINVOQ ER 30 MG tablets (30-count unit dose) on January 29, 2026, with completion scheduled for January 30, 2026. This non-set-aside competitive award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.99 million through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of brand-name and generic medications, vaccines, and medical supplies to military healthcare systems worldwide.
RINVOQ (upadacitinib) is a Janus kinase inhibitor indicated for rheumatoid arthritis and other inflammatory conditions, supporting the medical supply needs of military treatment facilities and veteran healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, maintains a registered SAM.gov profile and demonstrates substantial federal contracting experience across multiple therapeutic domains, positioning the company as a critical vendor for Department of Defense medical procurement through the DLA's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DR26FJK7Y?
SPE2DR26FJK7Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FJK7Y worth?
The government has obligated $65,818 on SPE2DR26FJK7Y.
Is contract SPE2DR26FJK7Y an order under another contract?
Yes. SPE2DR26FJK7Y is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK7Y competed?
The extent of competition for SPE2DR26FJK7Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award